In wild-type chemosensitive lung cancer or pancreatic cancer cells, cytotoxic drugs increase sphingomyelinase activity, thus enabling hydrolysis of sphingomyelin to ceramide, increasing ROS production, and leading to the release of thioredoxin-interacting protein (TXNIP) from thioredoxin. The gene discussed is TXNIP; the disease is lung cancer.